Codonopsis & Astragalus by Ron Teeguarden's Dragon Herbs — Ingredients, Evidence & Safety

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

ℹ️ Contains proprietary blend — exact ingredient amounts not disclosed

Label Data

3 Capsule(s) Serving Size

33 Servings

Botanical Product Type

0% Evidence Coverage

Supplement Facts — Evidence Check

Proprietary Extract Blend

1500 mg

Other Ingredients

Pullulan Polysaccharide Rice, Powder Bamboo Extract, Powder Rice Extract Blend

Label Claims — Verification

❓ All Other

❓ Structure/Function

All Other (100% of products) Structure/Function (81% of products) Nutrient (3% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Directions: Take 3 capsules, 2 times per day or as directed by a healthcare professional.

⚠️ Warnings & Precautions

Keep out of the reach of children.

🧪 Formulation Notes

Previously known as Ginseng and Astragalus Combination, Codonopsis & Astragalus has classically been called the "King of Combinations."

This formulation is both safe and effective.

Codonopsis & Astragalus 500 mg each

Pullulan caps - 100% natural, water-soluble polysaccharide produced through a fermentation process; vegetable origin; non-GMO; no starch, preservatives or chemical modifications; gluten free.

Product Details

UPC / SKU 6 79372 00310 2

DSLD Entry Date 2024-07-25

Product Type Botanical

Form Capsule

Brand Ron Teeguarden's Dragon Herbs

DSLD ID 316860

Data Updated 2026-04-11

Research Evidence

9 Research Sources

60 Avg Quality Score

5 Meta Analysis

2 Cochrane Review

1 Systematic Review

1 Rct

B Astragalus (a traditional Chinese medicine) for treating chronic kidney disease.

Cochrane Review The Cochrane database of systematic reviews

PubMed DOI Cochrane

B Oral Astragalus (Huang qi) for preventing frequent episodes of acute respiratory tract infection in children.

Cochrane Review The Cochrane database of systematic reviews

PubMed DOI Cochrane

B Evaluating traditional Chinese medicine (TCM) Jie Geng and Huang Qi combination on reducing surgical site infections in colorectal cancer surgeries: A systematic review and meta-analysis

Meta Analysis International wound journal 2024

PubMed DOI

B Chronic fatigue syndrome post-COVID-19: triple-blind randomised clinical trial of Astragalus root extract

Rct BMJ supportive & palliative care 2025

PubMed DOI

B Efficacy and potential pharmacological mechanism of Astragalus-Salvia miltiorrhiza combination in diabetic nephropathy: integrating meta-analysis, network pharmacology, molecular docking, and experimental validation

Meta Analysis Renal failure 2025

PubMed DOI

B Renal protective effects and mechanisms of Astragalus membranaceus for diabetic kidney disease in animal models: An updated systematic review and meta-analysis

Meta Analysis Phytomedicine : international journal of phytotherapy and phytopharmacology 2024

PubMed DOI

C Adjuvant therapy with Astragalus membranaceus for post-stroke fatigue: a systematic review

Systematic Review Metabolic brain disease 2020

PubMed DOI

C Efficacy of Astragalus Membranaceus (Huang Qi) for Cancer-Related Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Studies

Meta Analysis Integrative cancer therapies 2025

PubMed DOI

C The Effect of Astragalus on Humoral and Cellular Immune Response: A Systematic Review and Meta-Analysis of Human Studies

Meta Analysis Complementary medicine research 2023

PubMed DOI

View all evidence for Astragalus →